Results 121 to 130 of about 18,115 (178)

Pathway dysregulation and therapeutic resistance in glioblastoma: molecular mechanisms and emerging therapeutic targets. [PDF]

Future Sci OA
Li W, Chen JM, Ma YC.
europepmc   +1 more source

A Type II CDK6 Degrader Enables Cellular Targeting beyond the Limits of Type II Inhibition. [PDF]

J Am Chem Soc
Kim JH, Mills CE, Kozicka Z, Scott DC, Jin C, Jiang Z, Dwyer BG, Geng Q, Toenjes ST, Byun WS, ElHarouni D, Li H, Ligon KL, Thornhill AM, Jones HM, Romero BA, Hinshaw SM, Ebert BL, Schulman BA, Donovan KA, Fischer ES, Gray NS.   +21 more
europepmc   +1 more source

Optimizing third-line and beyond therapies for metastatic colorectal cancer in Taiwan: an evidence-based consensus. [PDF]

Ther Adv Med Oncol
Chang PH, Hsieh MC, Teng HW, Liang YH, Chen HH, Hsu HC, Jiang JK, Chiang FF, Lin J, Lin BR, Hsieh YY, Ke TW, Kuan FC, Huang WS, Lin BW, Chang YY, Su YL, Chen WT, Liu CK, Wang JY.   +19 more
europepmc   +1 more source

Synthesis and characterization of bevacizumab-functionalized nanoliposomes loaded with regorafenib and fluorescent carbon dots for triple-negative breast cancer theranostics. [PDF]

RSC Adv
Aryanmanesh A, Abbasi Kajani A.
europepmc   +1 more source

Consensus statement on the management of metastatic colorectal cancer beyond the second-line therapy in Saudi Arabia. [PDF]

Int J Colorectal Dis
Bazarbashi S, Alsharm A, Alshehri A, Ibnshamsah F, Tashkandi E, Alshammari K, Al-Hajeili M, Mahrous M, Alghmadi M, Aljubran A, Alkhayyat S, Elsamany S.   +11 more
europepmc   +1 more source

Notch3/4 Knockdown Inhibits Colon Adenocarcinoma Progression by Suppressing Tumor Cell Activity and Orchestrating VEGFA-Dependent Tumor Immune Microenvironment. [PDF]

Cancer Med
Liu W, Tang G, Li N, Wang J, Zhao H, Li C.   +5 more
europepmc   +1 more source

In silico repurposing of clinically approved drugs as potential BRAF inhibitors: a pharmacophore-based virtual screening and experimental investigation. [PDF]

Cancer Cell Int
Amini H, Ebrahimi N, Mousavirahimi S, Zamani M, Bagherzadeh K, Montazeri H, Azizian H.   +6 more
europepmc   +1 more source

Hypoxia-Stabilized HIF1α Restricts Hair Cell Reprogramming by Suppressing Wnt Signaling in the Mammalian Cochlea. [PDF]

Cells
Liu Q, Guo Y, Wang X, Wang S, Li A, Wan G.   +5 more
europepmc   +1 more source

Multifunctional hyaluronic acid-modified hollow MnO₂ nanoplatform co-delivering with L-Arginine and Regorafenib for synergistic therapy against colorectal cancer. [PDF]

Mater Today Bio
Li C, Liu W, Li N, Zhang Y, Wu K, Yu S.
europepmc   +1 more source

Efficacy of Hepatic Artery Infusion Chemotherapy Combined With Regorafenib and Sintilimab Versus Regorafenib Alone in MSS/pMMR Colorectal Cancer Liver Metastases After Second-Line Treatment Failure. [PDF]

Cancer Med
You R, Xu Q, Wang L, Leng B, Wang C, Yu Z, Lu Y, Diao L, Lu Y, Yin G.   +9 more
europepmc   +1 more source